Clinical Commissioning Urgent Policy Statement Antivirals for adults with recent onset (acute) hepatitis C (URN: 170135P) – NHS England and NHS Improvement

NHS England will routinely commission antivirals for adults with acute hepatitis C (HCV), including the treatment of acute HCV infection in immunosuppressed adults (e.g. post transplantation patients) in accordance with the criteria set out in this document.

Annual review of the epidemiology of Hepatitis C infection in Yorkshire and Humber: Field service Yorkshire and Humber – Public Health England

This report focuses on the epidemiology of hepatitis C in Yorkshire and Humber using mainly routinely available surveillance data.

Antiviral resistance testing in the management of hepatitis C virus infection: PHE Hepatitis C Virus Resistance Group – Public Health England

This working document, written by Public Health England’s (PHE) Hepatitis C Virus Resistance Group, aims to support clinicians treating people with HCV, where the issue of resistance may be a factor in clinical decision-making.

Hepatitis C treatment monitoring in England: Content, completeness and preliminary findings from the Hepatitis C patient registry and treatment outcome system – Public Health England

This report summarises the content and completeness of data contained within the Hepatitis C patient registry and treatment outcome system at the end of April 2018, enabling a preliminary assessment of HCV treatment and its monitoring in England.

A systematic review of the effectiveness and cost effectiveness of interventions aimed at raising awareness and engaging with groups who are at an increased risk of hepatitis B and C infection – Liverpool John Moores University Centre for Public Health

Hepatitis B and C virus infections represent a major public health problem. In England, and elsewhere in the UK, injecting drug use is the major risk factor for acquiring hepatitis C infection. Injecting drug use is also a risk factor for hepatitis

A practice survey of activities and interventions that aim to raise awareness among, and/or engage with, groups who are at an increased risk of hepatitis B and C infection – Liverpool John Moores University Centre for Public Health

Despite the publication of the Hepatitis C Action Plan for England in 2004, there is evidence of  considerable variation in hepatitis C testing, treatment, care and support services available in England. In addition, little is known about the provision and

A systematic review of qualitative research on the views, perspectives and experiences of hepatitis B and C testing among practitioners and people at greatest risk of infection – Liverpool John Moores University Centre for Public Health

The evidence identified for this review suggests that people from high risk groups may hold concepts of illness and disease that differ from biomedical understandings. Consequently people from high risk groups may have an incomplete or confused understanding of the

Burden of Liver Disease and Inequalities in the North West of England – Liverpool John Moores University Centre for Public Health

This report collates routinely available data on the burden of liver disease and describes its relationship with inequalities. We hope that it will be a useful resource for Directors of Public Health, health and wellbeing boards, commissioners and providers of

Population screening for early signs of alcohol-related liver disease in hazardous and harmful drinkers in Liverpool and Knowsley – Liverpool John Moores University Centre for Public Health

The Preventing Alcohol Harm in Liverpool and Knowsley (PrevAIL) project aims to estimate the prevalence of early stage liver disease and identifying optimal ways of engaging people with screening. To do this, the study uses conventional biomarkers of alcohol use

Hepatitis B vaccine for at risk infants – Public Health England

Information for GPs and practice nurses It recommends: When pregnant women attend for vaccination during pregnancy Ask mum if they have screened positive for hepatitis B Tell her to register their baby at the surgery as soon as possible when

Laboratory-confirmed hepatitis A and C (England and Wales), January to March 2018: Health Protection Report Volume 12 Number 31 – Public Health England

Laboratory reports of hepatitis A and C reported to Public Health England, laboratory-confirmed hepatitis A virus and hepatitis C reports in England and Wales in 2018.

Hepatitis C in the North West Annual report 2016 – Public Health England

Hepatitis C in the North West is still a major public health concern, however, rates since 2014 have remained stable. Estimates suggest at least 40,000 people across the North West acquired hepatitis C infection, and of those 27,000 have developed